FXH VS XBI

Exchange-Traded Funds (ETFs) have become indispensable tools for investors, offering diverse exposure across various sectors and asset classes. In this article, we will conduct an in-depth comparison between two prominent ETFs: FXH (First Trust Health Care AlphaDEX Fund) and XBI (SPDR S&P Biotech ETF). We will explore essential aspects, including ETF tickers, full names, issuers, sectors, top holdings, capitalization, strategy, tracking, and exposure.

FXH VS XBI: Overview

FXH and XBI are two ETFs that cater to distinct niches within the healthcare industry. FXH focuses on the broader healthcare sector, while XBI specifically targets biotechnology companies. This divergence in focus results in unique investment opportunities and risks, which we will dissect in the following sections.

FXH VS XBI: Sectors and Top Holdings

The FXH ETF provides exposure to a wide range of healthcare companies, including pharmaceuticals, biotechnology, and healthcare providers. Top holdings in FXH typically include well-established companies like Johnson & Johnson, Pfizer, and UnitedHealth Group. In contrast, XBI concentrates on the biotech sector and holds positions in companies such as Moderna, Amgen, and Regeneron. Understanding the sectors and top holdings is vital for investors seeking to align their investments with specific healthcare sub-industries.

FXH overlap FXH VS XBI

FXH VS XBI: Capitalization and Strategy

FXH boasts a substantial asset under management (AUM), indicating its popularity among investors seeking exposure to the broader healthcare market. XBI's strategy revolves around capitalizing on the growth potential of biotechnology companies. The differences in capitalization and strategy between these two ETFs can significantly influence potential returns and risks, necessitating careful consideration by investors.

FXH VS XBI: Tracking and Exposure

FXH aims to provide investors with exposure to the healthcare industry's performance as a whole. It typically tracks an index comprising various healthcare companies. On the other hand, XBI focuses on tracking an index of biotechnology stocks. Understanding these different tracking and exposure strategies is crucial for investors to choose the ETF that aligns with their investment objectives and risk tolerance.

Conclusion

FXH and XBI are distinct ETFs, each offering a specialized approach to investing within the healthcare sector. For investors interested in delving deeper into the holdings, correlations, overlaps, and various insights, ETF Insider stands as the ultimate tool to explore. With its user-friendly app, it provides comprehensive details on these and other financial instruments.

Disclaimer: This article does not provide any investment advisory services.

FXH ETF issuer
FXH ETF official page

Get started